Stay updated with breaking news from Molecular Diagnostics Program Mol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE - Foundation Medicine, Inc., and Natera, Inc., today announced the broad clinical launch of FoundationOneTracker, a personalized tissue-informed circulating tumor DNA test to monitor...
/PRNewswire/ -- The "Global MRD Testing Market: Focus on Technology, Application, End User, Region - Analysis and Forecast, 2022-2027" report has been added to...
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Global MRD Testing Market: Focus on Technology, Application, End User, Region - Analysis and Forecast,...
/PRNewswire/ -- NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a...